Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
2026 · 3rd Quarter (July 1 - Sep 30)
CARL ZEISS, INC.
Filed by ALPINE GROUP PARTNERS, LLC..
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Amendment
- Posted
- Oct 21, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ALPINE GROUP PARTNERS, LLC.
- Client
- CARL ZEISS, INC.
- Filing UUID
- f6a88322-6c8c-4879-ab89-cd07e93ebe4b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.